Cargando…

PSUN137 Suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity

Hyperinsulinemia is strongly linked with excessive body fat. However, with the exception of plasma glucose concentrations, the other factors regulating insulin secretion are under-studied. We examined the effects of hyperinsulinemia itself on beta cell insulin secretion during exogenous insulin and...

Descripción completa

Detalles Bibliográficos
Autores principales: Eyupoglu, Nesrin Damla, Laurenti, Marcello, Vella, Adrian, Jensen, Micheal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624858/
http://dx.doi.org/10.1210/jendso/bvac150.750
_version_ 1784822339861479424
author Eyupoglu, Nesrin Damla
Laurenti, Marcello
Vella, Adrian
Jensen, Micheal
author_facet Eyupoglu, Nesrin Damla
Laurenti, Marcello
Vella, Adrian
Jensen, Micheal
author_sort Eyupoglu, Nesrin Damla
collection PubMed
description Hyperinsulinemia is strongly linked with excessive body fat. However, with the exception of plasma glucose concentrations, the other factors regulating insulin secretion are under-studied. We examined the effects of hyperinsulinemia itself on beta cell insulin secretion during exogenous insulin and glucose infusions in adults with insulin-resistant upper body (UBO), insulin-sensitive lower body obesity (LBO) and non-obese controls. Data from the euglycemic, hyperinsulinemic clamp studies of 33 volunteers (9 controls, 5 LBO, 19 UBO) was analyzed; basal and insulin-suppressed (residual) insulin secretion rates were determined using deconvolution of C-peptide concentrations. Obesity phenotype was determined using waist: hip ratio and body composition was assessed with dual-energy X-ray absorptiometry and abdominal computed tomography. Plasma insulin concentrations were log transformed to achieve a normal distribution before statistical analysis. The plasma glucose concentration change during the clamp was 0.3 (SD: 3) mg/dl, and similar among groups (p=0.7). Median, achieved serum insulin concentrations was 66 (IQR: 45-105) mIU/mL, and greater in participants with obesity. Fasting insulin secretion rates were 0.093 (SD: 0.029), 0.158 (SD: 0.036), and 0.216 (0.078) nmol/min in controls, LBO and UBO, respectively (UBO p<0.001 vs. other groups). Insulin secretion was suppressed by 28% during hyperinsulinemia with no between group differences (p= 0.69). The ratios of insulin secretion rate (from C-peptide deconvolution) to serum insulin concentration (nmol/min per mIU/mL) was 0.058 (SD: 0.015) in controls, 0.090 (SD: 0.016) in LBO and 0.111 (SD: 0.039) in UBO (UBO vs. other groups P = 0.001). The ratio of insulin secretion rates to plasma insulin concentrations was correlated with BMI (r=0.69, P <0.001). We conclude that adults with obesity have greater residual insulin secretion during an exogenous insulin infusion and that this is related to upper body fat distribution. However, because the proportional suppression of endogenous insulin secretion is similar in these groups, this could indicate the primary abnormality is fasting insulin secretion. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m.
format Online
Article
Text
id pubmed-9624858
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96248582022-11-14 PSUN137 Suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity Eyupoglu, Nesrin Damla Laurenti, Marcello Vella, Adrian Jensen, Micheal J Endocr Soc Diabetes & Glucose Metabolism Hyperinsulinemia is strongly linked with excessive body fat. However, with the exception of plasma glucose concentrations, the other factors regulating insulin secretion are under-studied. We examined the effects of hyperinsulinemia itself on beta cell insulin secretion during exogenous insulin and glucose infusions in adults with insulin-resistant upper body (UBO), insulin-sensitive lower body obesity (LBO) and non-obese controls. Data from the euglycemic, hyperinsulinemic clamp studies of 33 volunteers (9 controls, 5 LBO, 19 UBO) was analyzed; basal and insulin-suppressed (residual) insulin secretion rates were determined using deconvolution of C-peptide concentrations. Obesity phenotype was determined using waist: hip ratio and body composition was assessed with dual-energy X-ray absorptiometry and abdominal computed tomography. Plasma insulin concentrations were log transformed to achieve a normal distribution before statistical analysis. The plasma glucose concentration change during the clamp was 0.3 (SD: 3) mg/dl, and similar among groups (p=0.7). Median, achieved serum insulin concentrations was 66 (IQR: 45-105) mIU/mL, and greater in participants with obesity. Fasting insulin secretion rates were 0.093 (SD: 0.029), 0.158 (SD: 0.036), and 0.216 (0.078) nmol/min in controls, LBO and UBO, respectively (UBO p<0.001 vs. other groups). Insulin secretion was suppressed by 28% during hyperinsulinemia with no between group differences (p= 0.69). The ratios of insulin secretion rate (from C-peptide deconvolution) to serum insulin concentration (nmol/min per mIU/mL) was 0.058 (SD: 0.015) in controls, 0.090 (SD: 0.016) in LBO and 0.111 (SD: 0.039) in UBO (UBO vs. other groups P = 0.001). The ratio of insulin secretion rates to plasma insulin concentrations was correlated with BMI (r=0.69, P <0.001). We conclude that adults with obesity have greater residual insulin secretion during an exogenous insulin infusion and that this is related to upper body fat distribution. However, because the proportional suppression of endogenous insulin secretion is similar in these groups, this could indicate the primary abnormality is fasting insulin secretion. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9624858/ http://dx.doi.org/10.1210/jendso/bvac150.750 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Diabetes & Glucose Metabolism
Eyupoglu, Nesrin Damla
Laurenti, Marcello
Vella, Adrian
Jensen, Micheal
PSUN137 Suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity
title PSUN137 Suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity
title_full PSUN137 Suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity
title_fullStr PSUN137 Suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity
title_full_unstemmed PSUN137 Suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity
title_short PSUN137 Suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity
title_sort psun137 suppression of endogenous insulin secretion during euglycemic hyperinsulinemia – effects of obesity
topic Diabetes & Glucose Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624858/
http://dx.doi.org/10.1210/jendso/bvac150.750
work_keys_str_mv AT eyupoglunesrindamla psun137suppressionofendogenousinsulinsecretionduringeuglycemichyperinsulinemiaeffectsofobesity
AT laurentimarcello psun137suppressionofendogenousinsulinsecretionduringeuglycemichyperinsulinemiaeffectsofobesity
AT vellaadrian psun137suppressionofendogenousinsulinsecretionduringeuglycemichyperinsulinemiaeffectsofobesity
AT jensenmicheal psun137suppressionofendogenousinsulinsecretionduringeuglycemichyperinsulinemiaeffectsofobesity